Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xemplar Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of high-quality generic and branded drug products for the U.S. market. Based in New Jersey, the company utilizes a strategic approach to identify and fill gaps in the pharmaceutical supply chain, particularly in the area of complex oral solids. Their business model emphasizes efficiency and cost-effectiveness, aiming to provide affordable therapeutic options to patients and healthcare providers. Xemplar's portfolio includes products across multiple therapeutic areas, including gastrointestinal health and pain management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xemplar Pharmaceuticals.